Article content
CHEO in Ottawa and Shriners Hospitals for Children Canada in Montreal announced a joint fellowship on Dec. 6 aimed at advancing health care and research into bone disorders in children.
Article content
The four-year fellowship involves training with experts at both CHEO and the Montreal hospital. Funded by Shriners Hospitals for Children Canada via the Tunis Shriners of Ottawa, it is the first of its kind in North America, according to the CHEO Research Institute.
Article content
Fellows will spend four years with pediatric bone disorder experts, two years at CHEO and two years at Shriners Hospital for Children in Montreal.
In Ottawa, Dr. Leanne Ward, a pediatric endocrinologist and scientific director of the Ottawa Pediatric Bone Health Research Group at the CHEO Research Institute, will lead the fellowship. Her research includes the study of novel drugs to mitigate the consequences of rare bone diseases and therapeutic trials in pediatric-onset bone disorders.
Dr. Frank Rauch, a clinician-scientist at the Shriners Hospital for Children, will lead the second half of the fellowship. He oversees a research program focused on improving bone health in children and collaborates with Statistic Canada in a national population-based study that assesses muscle and bone health in Canadians.
Dr. Jason Berman, CEO and scientific director of the CHEO Research Institute and vice-president of research at CHEO called the fellowship an example of transformative collaboration in action.
“Together, we are building the future of pediatric care in rare bone disorders by training the next generation of clinician-scientists,” said Berman.
Recommended from Editorial
Share this article in your social network